H. Kwasny

Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage

R. Lorenz, J. Kienast, Ulrich Otto, 2003, European journal of gastroenterology & hepatology.

Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range.

A. Greinacher, H. Kwasny, P. Eichler, 2000, Blood.

HBW 023 (recombinant hirudin) for the acceleration of thrombolysis and prevention of coronary reocclusion in acute myocardial infarction: results of a dose‐finding study (HIT‐II) by the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte

U. Tebbe, U. Zeymer, A. Jessel, 1998, Coronary artery disease.

Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.

U. Janssens, A. Greinacher, H. Kwasny, 1999, Circulation.

Effects of new somatostatin analogs on the cell proliferation of colonic crypts and colonic cancers in rats

M. Pawlikowski, H. Kwasny, A. Lachowicz-Ochędalska, 1993, Neuropeptides.

Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range.

H. Kwasny, P. Eichler, N. Lubenow, 2000, Blood.